Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dexmedetomidine for pain management in pediatric ALL patients during blood sampling
IRCT20190804044429N11Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Mazandaran University of Medical Sciences. Started May 2024; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20190804044429N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190804044429N11.